BRAF V600E MUTATION POSITIVE
Clinical trials for BRAF V600E MUTATION POSITIVE explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E MUTATION POSITIVE trials appear
Sign up with your email to follow new studies for BRAF V600E MUTATION POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo shows promise in shrinking hard-to-treat colon tumors before surgery
Disease control Recruiting nowThis study tests whether giving two targeted drugs (encorafenib and cetuximab) before surgery can shrink tumors in people with a specific genetic mutation (BRAF V600E) in localized colon or upper rectal cancer. About 30 participants will receive the drug combination for a short t…
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: PHASE2 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
Researchers launch major data hunt for rare colorectal cancer mutation
Knowledge-focused Recruiting nowThis study gathers medical information and biological samples from 400 adults with metastatic colorectal cancer that has a specific genetic change called BRAFV600E. The goal is to learn how this cancer is treated in real-world settings and how long people live. No new treatments …
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: NA • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC